A Global Movement of Hope: Clubhouse International's Mental Health Advocacy Initiative 2025
New York, New York--(Newsfile Corp. - April 23, 2025) - Advocacy efforts have become more essential and urgent as mental health challenges sweep through continents. These issues are global concerns, as seen from the silent crises in underserved communities to the growing sense of disconnection in wealthier nations. Clubhouse International, a forward-thinking New York-based nonprofit organization, believes collaborative, sustained, and compassionate responses are needed. Hence, it creates platforms rooted in dignity, purpose, and above all, hope.
Clubhouse International
Established in 1994 with roots in 1948, Clubhouse International has been known for empowering individuals living with mental illness to reclaim their lives through community and connection. Employing the Clubhouse Model, the organization provides safe, inclusive environments where members receive support to build meaningful relationships, pursue education, obtain employment, and access housing and healthcare.
Clubhouse International recognizes how systemic issues affecting mental health care are becoming more severe amid growing uncertainty. Because of the complex landscape, its local Clubhouses are facing challenges that might leave vulnerable populations without access to essential services. This crisis mirrors the global truth that mental health support structures are usually low in priority, making it one of the first to face financial shortfalls despite being integral to societal well-being.
The stigma surrounding mental illness also continues to hinder progress. Clubhouse International offers a vision that shifts away from an underfunded, misunderstood, and invisible landscape. It champions mutual respect and shared humanity. Anna Sackett Rountree, Director of Communications for Clubhouse International, notes: "Local leaders and global collaboration is needed to address these challenges. We can't afford to silo our solutions when the need is so universal."
This spirit of innovation and collaboration on a local and global scale comes alive in Clubhouse International's advocacy work, especially during Mental Health Awareness Month in May. This year, the organization is leading multiple initiatives aiming to raise awareness, inspire action, and systemic change.
Its Clubhouse Giving Day, a global day of fundraising and solidarity, is one of these innovative initiatives. This annual campaign mobilizes the Clubhouse community globally to celebrate the impact of the Clubhouse Model. The individual donations, community fundraisers, and widespread social media engagement made possible during this day are essential in sustaining and extending the reach of Clubhouses worldwide. Every dollar raised contributes to expanding access, supporting new Clubhouse development, and changing lives by providing opportunities for employment, education, and friendship to those usually left behind.
The Clubhouse International World Seminar complements these efforts. This five-day conference is a vibrant forum for knowledge exchange, inspiration, and strategy-building. Here, 700 participants from different U.S. states and countries share best practices, new innovations, and success stories. Topics can be anything enlightening, from strengthening employment programs and community partnerships to exploring governance, inclusion, and wellness.
For this year's World Seminar, guest speakers include Seth Kahan, founder and CEO of Visionary Leadership, and Andrej Vrsansky, President at Mental Health Europe and CEO at the League for Mental Health in Slovakia. They will offer insights that can help participants envision a future where mental health systems are holistic, person-centered, and built around recovery.
In tandem with these global efforts, Clubhouse International also focuses on strategic, local engagement through the US Clubhouse Advocacy Week of Action. This initiative invites Clubhouses across the country to host open houses, welcome policymakers, and share stories that highlight the model's impact. "Last year, 40 Clubhouses across 18 states and Washington, DC, participated," shares Rountree. "We showed lawmakers how impactful Clubhouses can be when it comes to mental health recovery and how adopting policies supporting psychosocial rehabilitation and sustained funding can make a sustainable difference for individuals and communities.
The nonprofit is a founder and participant of Mental Health Action Day, powered by MTV, which encourages individuals and institutions to improve mental health awareness and access. It calls people to get involved, share their stories, and advocate for change in their communities.
All these initiatives embody Clubhouse International's philosophy that solutions must be informed by real-world needs, the voice of lived experience, cultural context, and best practices. Moreover, they capture the organization's core belief that mental health is a universal human right and recovery must be available to everyone in all communities worldwide.
Clubhouse International emphasizes that change is happening, but it can't continue in isolation. The future of mental health care depends on collective action and bold advocacy.
For Clubhouse International, every Clubhouse is a lifeline. Every voice in support is part of the solution. Lastly, every contribution fuels a global movement that brings people in from the margins and places them at the center of community and care.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Novo Nordisk (NVO) Receives FDA Approval for Wegovy
Novo Nordisk (NYSE:NVO) is one of the Most Profitable Large Cap Stocks to Buy According to Analysts. On August 15, Novo Nordisk (NYSE:NVO) announced that the FDA had approved the use of its new drug Wegovy to treat adults with noncirrhotic metabolic dysfunction-associated steatohepatitis. The drug also moderates advanced liver fibrosis. The approval follows positive results from the ESSENCE trial, where the drug depicted better results compared to the placebo. At week 72, 36.8% of patients taking Wegovy improved their liver fibrosis without worsening steatohepatitis. Whereas the placebo only improved results in 22.4% of the patients. With the approval, Wegovy is now the first and only GLP-1 drug approved for noncirrhotic metabolic dysfunction-associated steatohepatitis. An elderly couple receiving insulin from a pharmacist, representing healthcare company's successful pharmaceutical products. Novo Nordisk (NYSE:NVO) is a global healthcare company specializing in diabetes and obesity care. While we acknowledge the potential of NVO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
3 hours ago
- Yahoo
US pediatricians' new COVID-19 shot recommendations differ from CDC advice
NEW YORK (AP) — For the first time in 30 years, the American Academy of Pediatrics is substantially diverging from U.S. government vaccine recommendations. The group's new COVID-19 recommendations — released Tuesday — come amid a tumultuous year for public health, as vaccine skeptics have come into power in the new Trump administration and government guidance has become increasingly confusing. This isn't going to help, acknowledged Dr. James Campbell, vice chair of the AAP infectious disease committee. 'It is going to be somewhat confusing. But our opinion is we need to make the right choices for children to protect them,' he added. The AAP is strongly recommending COVID-19 shots for children ages 6 months to 2 years. Shots also are advised for older children if parents want their kids vaccinated, the AAP said. That differs from guidance established under U.S. Health Secretary Robert F. Kennedy Jr., which doesn't recommend the shots for healthy children of any age but says kids may get the shots in consultation with physicians. Children ages 6 months to 2 years are at high risk for severe illness from COVID-19, and it was important that recommendations continue to emphasize the need for them to get vaccinated, said Campbell, a University of Maryland infectious diseases expert. Vaccinations also are recommended for older children who have chronic lung diseases or other conditions that put them at higher risk for severe disease, the AAP said. The 95-year-old Itasca, Illinois-based organization has issued vaccination recommendations for children since the 1930s. In 1995, it synced its advice with recommendations made by the federal government's Centers for Disease Control and Prevention. There have been a few small differences between AAP and CDC recommendations since then. For example, the AAP has advised that children get HPV vaccinations starting at age 9; the CDC says that's OK but has emphasized vaccinations at ages 11 and 12. But in 30 years, this is the first time the recommendations have differed 'in a significant or substantial way,' Campbell said. Until recently, the CDC — following recommendations by infectious disease experts — has been urging annual COVID-19 boosters for all Americans ages 6 months and older. But in May, U.S. Health Secretary Robert F. Kennedy Jr. announced that COVID-19 vaccines are no longer recommended for healthy children and pregnant women. A few days later, the CDC issued language that healthy children may get the shots, but that there was no longer a 'should' recommendation. The idea that healthy older kids may be able to skip COVID-19 boosters has been brewing for some time among public health experts. As the COVID-19 pandemic has waned, experts have increasingly discussed the possibility of focusing vaccination efforts on people 65 and older — who are among those most as risk for death and hospitalization. A CDC expert panel in June was set to make recommendations about the fall shots. Among the options the panel was considering was whether suggest shots for high-risk groups but still giving lower-risk people the choice to get vaccinated. But Kennedy bypassed the group, and also decided to dismiss the 17-member panel and appoint his own, smaller panel, that included vaccine skeptics. Kennedy also later excluded the AAP, the American Medical Association and other top medical organizations from working with the advisers to establish vaccination recommendations. Kennedy's new vaccine panel has yet to vote on COVID-19 shot recommendations. The panel did endorse continuing to recommend fall flu vaccinations, but also made a decision that led to another notable difference with the AAP. The new advisory panel voted that people should only get flu vaccines that are packaged as single doses and do not contain the preservative thimerosal. The AAP said there is no evidence of harm from the preservative, and recommended doctors use any licensed flu vaccine product that's appropriate for the patient. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Associated Press
3 hours ago
- Associated Press
US pediatricians' new COVID-19 shot recommendations differ from CDC advice
NEW YORK (AP) — For the first time in 30 years, the American Academy of Pediatrics is substantially diverging from U.S. government vaccine recommendations. The group's new COVID-19 recommendations — released Tuesday — come amid a tumultuous year for public health, as vaccine skeptics have come into power in the new Trump administration and government guidance has become increasingly confusing. This isn't going to help, acknowledged Dr. James Campbell, vice chair of the AAP infectious disease committee. 'It is going to be somewhat confusing. But our opinion is we need to make the right choices for children to protect them,' he added. The AAP is strongly recommending COVID-19 shots for children ages 6 months to 2 years. Shots also are advised for older children if parents want their kids vaccinated, the AAP said. That differs from guidance established under U.S. Health Secretary Robert F. Kennedy Jr., which doesn't recommend the shots for healthy children of any age but says kids may get the shots in consultation with physicians. Children ages 6 months to 2 years are at high risk for severe illness from COVID-19, and it was important that recommendations continue to emphasize the need for them to get vaccinated, said Campbell, a University of Maryland infectious diseases expert. Vaccinations also are recommended for older children who have chronic lung diseases or other conditions that put them at higher risk for severe disease, the AAP said. The 95-year-old Itasca, Illinois-based organization has issued vaccination recommendations for children since the 1930s. In 1995, it synced its advice with recommendations made by the federal government's Centers for Disease Control and Prevention. There have been a few small differences between AAP and CDC recommendations since then. For example, the AAP has advised that children get HPV vaccinations starting at age 9; the CDC says that's OK but has emphasized vaccinations at ages 11 and 12. But in 30 years, this is the first time the recommendations have differed 'in a significant or substantial way,' Campbell said. Until recently, the CDC — following recommendations by infectious disease experts — has been urging annual COVID-19 boosters for all Americans ages 6 months and older. But in May, U.S. Health Secretary Robert F. Kennedy Jr. announced that COVID-19 vaccines are no longer recommended for healthy children and pregnant women. A few days later, the CDC issued language that healthy children may get the shots, but that there was no longer a 'should' recommendation. The idea that healthy older kids may be able to skip COVID-19 boosters has been brewing for some time among public health experts. As the COVID-19 pandemic has waned, experts have increasingly discussed the possibility of focusing vaccination efforts on people 65 and older — who are among those most as risk for death and hospitalization. A CDC expert panel in June was set to make recommendations about the fall shots. Among the options the panel was considering was whether suggest shots for high-risk groups but still giving lower-risk people the choice to get vaccinated. But Kennedy bypassed the group, and also decided to dismiss the 17-member panel and appoint his own, smaller panel, that included vaccine skeptics. Kennedy also later excluded the AAP, the American Medical Association and other top medical organizations from working with the advisers to establish vaccination recommendations. Kennedy's new vaccine panel has yet to vote on COVID-19 shot recommendations. The panel did endorse continuing to recommend fall flu vaccinations, but also made a decision that led to another notable difference with the AAP. The new advisory panel voted that people should only get flu vaccines that are packaged as single doses and do not contain the preservative thimerosal. The AAP said there is no evidence of harm from the preservative, and recommended doctors use any licensed flu vaccine product that's appropriate for the patient. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
